Claire Friedman, MD

The panel concludes their discussion with a conversation about the myths surrounding the treatment of cervical cancer.

Experts on cervical cancer offer provide comprehensive insights on the challenges patients experience and discuss ways to improve care.

Linda Ryan, a recurrent cervical cancer survivor and patient advocate, offers advice for patients undergoing cervical cancer treatment on advocating for yourself and communicating with family.

A gynecologic medical oncologist, a registered nurse, and a patient advocate have a conversation about shared decision-making for patients with cervical cancer.

The panel discusses unmet needs in the treatment landscape for patients with cervical cancer and the importance of clinical trials.

Comprehensive insights on the journey of a patient with cervical cancer and treatment options upon progression, with a focus on tisotumab vedotin.

Expert perspectives on how to best match the right treatment with the right patient with cervical cancer.

Clinical insights on treatment options for patients with newly diagnosed metastatic cervical cancer, with a focus on immunotherapy and the KEYNOTE-826 trial.

Experts on cervical cancer discuss treatment options for patients with primary or recurrent cervical cancer and review the GOG 240 study.

The expert panel discusses ways doctors can make cervical cancer screening easier in terms of access and the patient experience.

Linda Ryan, a patient advocate, details her treatment journey with cervical cancer and discusses resources available to patients.

After introducing the panel, Claire Friedman, MD, provides a brief overview of the screening process, prognosis, and treatment of cervical cancer.

Claire Friedman, Memorial Sloan Kettering Cancer Center, discusses some of the factors that doctors and elderly patients with melanoma should discuss before deciding on a treatment plan with immunotherapy. Immunotherapy is not one-size-fits all, and patients should be informed of the pros and cons of each option.